DOP2001000130A - Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina - Google Patents

Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina

Info

Publication number
DOP2001000130A
DOP2001000130A DO2001000130A DO2001000130A DOP2001000130A DO P2001000130 A DOP2001000130 A DO P2001000130A DO 2001000130 A DO2001000130 A DO 2001000130A DO 2001000130 A DO2001000130 A DO 2001000130A DO P2001000130 A DOP2001000130 A DO P2001000130A
Authority
DO
Dominican Republic
Prior art keywords
oral administration
ciprofloxacine
administration system
daily intake
agent
Prior art date
Application number
DO2001000130A
Other languages
English (en)
Spanish (es)
Inventor
Naresh Talwar
John N Staniforth
Ashok Rampal
Gour Mukherji
Badri N Vishwanathan
Brij Khera
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of DOP2001000130A publication Critical patent/DOP2001000130A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DO2001000130A 2000-03-03 2001-03-02 Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina DOP2001000130A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03

Publications (1)

Publication Number Publication Date
DOP2001000130A true DOP2001000130A (es) 2004-03-31

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2001000130A DOP2001000130A (es) 2000-03-03 2001-03-02 Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina

Country Status (31)

Country Link
EP (1) EP1263409A1 (xx)
JP (1) JP2003525229A (xx)
KR (1) KR20030009374A (xx)
CN (1) CN1420763A (xx)
AP (2) AP2001002084A0 (xx)
AR (1) AR032614A1 (xx)
AU (1) AU3589701A (xx)
BG (1) BG107055A (xx)
BR (1) BR0108958A (xx)
CA (1) CA2400950A1 (xx)
CZ (1) CZ20022883A3 (xx)
DO (1) DOP2001000130A (xx)
EA (1) EA200200914A1 (xx)
EC (1) ECSP013952A (xx)
EE (1) EE200200497A (xx)
GT (1) GT200100033A (xx)
HN (1) HN2001000038A (xx)
HR (1) HRP20020715A2 (xx)
HU (1) HUP0204417A3 (xx)
IL (1) IL151553A0 (xx)
IS (1) IS6532A (xx)
MX (1) MXPA02008568A (xx)
NO (1) NO20024108L (xx)
NZ (1) NZ520927A (xx)
OA (1) OA12381A (xx)
PE (1) PE20011113A1 (xx)
PL (1) PL365071A1 (xx)
SK (1) SK12542002A3 (xx)
WO (1) WO2001064183A1 (xx)
YU (1) YU66202A (xx)
ZA (1) ZA200206764B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
WO2016115253A1 (en) 2015-01-14 2016-07-21 The Regents Of The University Ofcolordo, A Body Corporate Insulin mimotopes and methods of using the same
EP3419669A4 (en) * 2016-02-23 2019-10-30 Matripharm International Inc. DOUBLE-SPEED RELEASE COMPOSITION WITH HIGH MEDICAL DRUG CHARGE
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (zh) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 一种乳酸环丙沙星泡腾片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE19839057A1 (de) * 1998-08-28 2000-03-02 Koch Berthold Spülluft-Regler für eine Trockenvorrichtung für Druckluft
EA004443B1 (ru) * 1998-09-14 2004-04-29 Рэнбакси Лабораториз Лимитед Лекарственная форма для контролируемого высвобождения ципрофлоксацина для приема один раз в день

Also Published As

Publication number Publication date
OA12381A (en) 2004-09-06
CZ20022883A3 (cs) 2003-04-16
KR20030009374A (ko) 2003-01-29
WO2001064183A1 (en) 2001-09-07
IS6532A (is) 2002-08-28
EP1263409A1 (en) 2002-12-11
CN1420763A (zh) 2003-05-28
HN2001000038A (es) 2005-03-23
NO20024108D0 (no) 2002-08-28
AU3589701A (en) 2001-09-12
BG107055A (bg) 2003-06-30
MXPA02008568A (es) 2003-02-24
HRP20020715A2 (en) 2004-12-31
AP2002002627A0 (en) 2002-09-30
IL151553A0 (en) 2003-04-10
PL365071A1 (en) 2004-12-27
AP1485A (en) 2005-10-31
NO20024108L (no) 2002-10-25
GT200100033A (es) 2001-10-25
HUP0204417A2 (en) 2003-05-28
AR032614A1 (es) 2003-11-19
CA2400950A1 (en) 2001-09-07
PE20011113A1 (es) 2001-10-14
YU66202A (sh) 2005-09-19
EA200200914A1 (ru) 2003-02-27
ZA200206764B (en) 2003-03-04
BR0108958A (pt) 2003-09-30
HUP0204417A3 (en) 2005-03-29
NZ520927A (en) 2003-06-30
SK12542002A3 (sk) 2003-05-02
JP2003525229A (ja) 2003-08-26
AP2001002084A0 (en) 2001-03-31
EE200200497A (et) 2004-02-16
ECSP013952A (es) 2002-04-23

Similar Documents

Publication Publication Date Title
RS50303B (sr) Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
EP1790340A3 (en) Combination chemotherapy
IL112778A0 (en) Substituted heterocycles, their preparation and pharmaceutical compositions containing them
DK0938316T3 (da) Opioidantagonistholdig galenisk formulering
NO993520L (no) Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
HUP0302319A2 (hu) Gyógyszerkészítmények gyógyászati hatóanyagok szájon át történő bejuttatására
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
DOP2001000130A (es) Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
MY129314A (en) Pharmaceutical composition comprising sumatriptan
BRPI0412364A (pt) composição farmacêutica sólida, compreendendo amisulpride
SE0001916D0 (sv) Novel formulation
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
FR2793685B1 (fr) Compositions pharmaceutiques, destinees a l'administration par voie orale de phloroglucinol et leur preparation
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DE59708495D1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
GEP20043377B (en) Pharmaceutical Complex
UY26605A1 (es) Sistema de administración oral controlada para la ingestión diaria de ciprofloxacina